Infirst gains Mylanta and Mylicon rights in US

4 March 2015 - Deborah Wilkes

Archived

Infirst Healthcare has gained the rights to market Johnson & Johnson's Mylanta and Mylicon ranges of gastrointestinal remedies in the US.

Click tags below for more information on topics:

Infirst Healthcare

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: